GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Wuhan Hiteck Biological Pharma Co Ltd (SZSE:300683) » Definitions » Days Payable

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Days Payable : 54.01 (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is Wuhan Hiteck Biological Pharma Co Days Payable?

Wuhan Hiteck Biological Pharma Co's average Accounts Payable for the three months ended in Mar. 2024 was ¥46.9 Mil. Wuhan Hiteck Biological Pharma Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ¥79.3 Mil. Hence, Wuhan Hiteck Biological Pharma Co's Days Payable for the three months ended in Mar. 2024 was 54.01.

The historical rank and industry rank for Wuhan Hiteck Biological Pharma Co's Days Payable or its related term are showing as below:

SZSE:300683' s Days Payable Range Over the Past 10 Years
Min: 49.82   Med: 75.89   Max: 90.21
Current: 49.82

During the past 11 years, Wuhan Hiteck Biological Pharma Co's highest Days Payable was 90.21. The lowest was 49.82. And the median was 75.89.

SZSE:300683's Days Payable is ranked worse than
75.28% of 971 companies
in the Drug Manufacturers industry
Industry Median: 88.97 vs SZSE:300683: 49.82

Wuhan Hiteck Biological Pharma Co's Days Payable declined from Mar. 2023 (69.42) to Mar. 2024 (54.01). It may suggest that Wuhan Hiteck Biological Pharma Co accelerated paying its suppliers.


Wuhan Hiteck Biological Pharma Co Days Payable Historical Data

The historical data trend for Wuhan Hiteck Biological Pharma Co's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Wuhan Hiteck Biological Pharma Co Days Payable Chart

Wuhan Hiteck Biological Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 89.58 81.67 70.52 56.45 58.25

Wuhan Hiteck Biological Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.42 54.24 46.76 41.64 54.01

Competitive Comparison of Wuhan Hiteck Biological Pharma Co's Days Payable

For the Drug Manufacturers - Specialty & Generic subindustry, Wuhan Hiteck Biological Pharma Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuhan Hiteck Biological Pharma Co's Days Payable Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Wuhan Hiteck Biological Pharma Co's Days Payable distribution charts can be found below:

* The bar in red indicates where Wuhan Hiteck Biological Pharma Co's Days Payable falls into.



Wuhan Hiteck Biological Pharma Co Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Wuhan Hiteck Biological Pharma Co's Days Payable for the fiscal year that ended in Dec. 2023 is calculated as

Days Payable (A: Dec. 2023 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2022 ) + Accounts Payable (A: Dec. 2023 )) / count ) / Cost of Goods Sold (A: Dec. 2023 )*Days in Period
=( (58.052 + 52.079) / 2 ) / 345.055*365
=55.0655 / 345.055*365
=58.25

Wuhan Hiteck Biological Pharma Co's Days Payable for the quarter that ended in Mar. 2024 is calculated as:

Days Payable (Q: Mar. 2024 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2023 ) + Accounts Payable (Q: Mar. 2024 )) / count ) / Cost of Goods Sold (Q: Mar. 2024 )*Days in Period
=( (52.079 + 41.745) / 2 ) / 79.252*365 / 4
=46.912 / 79.252*365 / 4
=54.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuhan Hiteck Biological Pharma Co Days Payable Related Terms

Thank you for viewing the detailed overview of Wuhan Hiteck Biological Pharma Co's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuhan Hiteck Biological Pharma Co (SZSE:300683) Business Description

Traded in Other Exchanges
N/A
Address
Hite Science and Technology Park, Wuhan Economic and Technological Development Zone, Hubei Province, Wuhan, CHN, 430056
Wuhan Hiteck Biological Pharma Co Ltd is a biopharmaceutical manufacturing enterprise in China. The company is primarily engaged in the development, production and sale of biological products. Its product portfolio comprises rat nerve growth factor freeze-dried powder injection, injection of anti-hepatitis B transfer factor freeze-dried powder injection, thrombin and other chemicals. The company also has more than 20 kinds of products such as hepatitis B treatment drug op Heparin and hemostatic agent thrombin.
Executives
Yan Jie Director
Li Sheng Qiang Executives

Wuhan Hiteck Biological Pharma Co (SZSE:300683) Headlines

No Headlines